DE69716094D1 - Bromotiacumicin verbindungen - Google Patents

Bromotiacumicin verbindungen

Info

Publication number
DE69716094D1
DE69716094D1 DE69716094T DE69716094T DE69716094D1 DE 69716094 D1 DE69716094 D1 DE 69716094D1 DE 69716094 T DE69716094 T DE 69716094T DE 69716094 T DE69716094 T DE 69716094T DE 69716094 D1 DE69716094 D1 DE 69716094D1
Authority
DE
Germany
Prior art keywords
bromotiacumicin
connections
bromotiacumicin connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69716094T
Other languages
English (en)
Other versions
DE69716094T2 (de
Inventor
E Hochlowski
Marianna Jackson
B Mcalpine
R Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69716094D1 publication Critical patent/DE69716094D1/de
Application granted granted Critical
Publication of DE69716094T2 publication Critical patent/DE69716094T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69716094T 1996-07-12 1997-06-24 Bromotiacumicin verbindungen Expired - Lifetime DE69716094T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/678,906 US5767096A (en) 1996-07-12 1996-07-12 Bromotiacumicin compounds
PCT/US1997/011064 WO1998002447A1 (en) 1996-07-12 1997-06-24 Bromotiacumicin compounds

Publications (2)

Publication Number Publication Date
DE69716094D1 true DE69716094D1 (de) 2002-11-07
DE69716094T2 DE69716094T2 (de) 2003-06-05

Family

ID=24724791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716094T Expired - Lifetime DE69716094T2 (de) 1996-07-12 1997-06-24 Bromotiacumicin verbindungen

Country Status (20)

Country Link
US (1) US5767096A (de)
EP (1) EP0923594B1 (de)
JP (1) JP2000515512A (de)
KR (1) KR100476799B1 (de)
CN (1) CN1149220C (de)
AR (1) AR007854A1 (de)
AT (1) ATE225364T1 (de)
AU (1) AU730839B2 (de)
BR (1) BR9710250A (de)
CA (1) CA2257984A1 (de)
CZ (1) CZ294843B6 (de)
DE (1) DE69716094T2 (de)
DK (1) DK0923594T3 (de)
ES (1) ES2186900T3 (de)
HU (1) HU224966B1 (de)
IL (1) IL127540A (de)
NZ (1) NZ333258A (de)
PT (1) PT923594E (de)
WO (1) WO1998002447A1 (de)
ZA (1) ZA975861B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
ES2527052T3 (es) * 2002-07-29 2015-01-20 Optimer Pharmaceuticals, Inc. Producción de tiacumicina
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
ES2713954T3 (es) * 2004-05-14 2019-05-24 Merck Sharp & Dohme Tratamiento de enfermedades asociadas al uso de antibióticos
MX2007009196A (es) * 2005-01-31 2009-02-25 Optimer Pharmaceuticals Inc Compuestos macrocilicos de 18 miembros y analogos de los mismos.
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
CN102115757B (zh) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
IN2013MU00711A (de) * 2013-03-08 2015-06-26 Cipla Ltd
DK3139932T3 (en) 2014-05-09 2018-11-12 Astellas Pharma Europe Ltd The treatment regimen for thiacumicin compound
EP3316892B1 (de) 2015-07-03 2023-07-19 Tillotts Pharma AG Neuartiges dosierschema mit tiacumicinverbindung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds

Also Published As

Publication number Publication date
HUP9903902A2 (hu) 2001-05-28
IL127540A (en) 2004-05-12
KR20000023662A (ko) 2000-04-25
CA2257984A1 (en) 1998-01-22
WO1998002447A1 (en) 1998-01-22
CZ294843B6 (cs) 2005-03-16
EP0923594B1 (de) 2002-10-02
JP2000515512A (ja) 2000-11-21
CN1149220C (zh) 2004-05-12
AU730839B2 (en) 2001-03-15
DK0923594T3 (da) 2003-02-10
CZ2899A3 (cs) 1999-03-17
EP0923594A1 (de) 1999-06-23
HUP9903902A3 (en) 2001-06-28
IL127540A0 (en) 1999-10-28
NZ333258A (en) 2000-07-28
KR100476799B1 (ko) 2005-03-16
PT923594E (pt) 2003-02-28
ATE225364T1 (de) 2002-10-15
BR9710250A (pt) 1999-08-10
CN1225096A (zh) 1999-08-04
HU224966B1 (en) 2006-04-28
DE69716094T2 (de) 2003-06-05
US5767096A (en) 1998-06-16
AR007854A1 (es) 1999-11-24
AU3504697A (en) 1998-02-09
ES2186900T3 (es) 2003-05-16
ZA975861B (en) 1998-01-30

Similar Documents

Publication Publication Date Title
DE69528825D1 (de) Dendrime verbindungen
ATE298739T1 (de) Calcylitische verbindungen
DE69805769D1 (de) Entzündungshemmende verbindungen
FI960525A0 (fi) Framstaellning av mellandestillat
FI961551A0 (fi) Menylett utforming av kortmeddelanden
FI962166A0 (fi) Foerfarande foer bestaemmande av utbredningsdaempning av radiovaogor
DE69518667D1 (de) Antiinflammatorische verbindungen
ATE227273T1 (de) Neue verbindungen
DE69807105D1 (de) Photochromische verbindungen
DE69716094D1 (de) Bromotiacumicin verbindungen
NO992932D0 (no) Innkapsling
FI960501A0 (fi) Foerfarande foer omkastning av uppkopplingsriktningen av samtal
DE69739606D1 (de) Ichten verbindungsstellen
DE59712516D1 (de) Chirale Verbindungen
FI960962A0 (fi) Foerfarande foer framstaellning av en flerskiktskartongprofil
FI961041A0 (fi) Klingledare av saogmaskin
ID17224A (id) Sediaan
NO962452D0 (no) Tannbehandlingssystem
FI961474A0 (fi) Foerfarande foer stegloes bearbetning av signalen
FI960321A0 (fi) Foerfarande foer behandling av CD-skiva
FI961483A0 (fi) Maetning av planhet
FI961509A0 (fi) Foerfarande foer fyllning av en satsvis kokare
FI961256A0 (fi) Anordning foer aostadkommande av en luftstroem
FI961217A0 (fi) Anordning foer reglering av en luftstroem
FI961127A0 (fi) Anordning foer rengoering av takraennor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition